chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Following my booster shot in December 2022, my menstral cycle began being late.  In January it was 10 days late, in February it was 15 days late, March never showed. I was diagnosed with a cyst and given medication to restabilize my cycles.
I had dose 2 of  Moderna vaccine, less than 12-14 hrs after it I literally dropped to the floor, had severe joint pain, muscle spasms, and my Reynards Syndrome went into hyper speed.  It has not stopped sense.  - Severe swelling with pain reactions to the cold - debilitating arthritis in all joints ( worse during menstral cycle) - constant swelling of my hands, legs, and feet - Spasms and nerve pain  - extreme Fatigue - All blood work normal and rheumatory arthritis negative - Daily Heart Flutters
48-72 hours of fever, reaching 105 deg max. Vomiting, lack cough, nasal congestion. Resolved within 72 hours of beginning. Visited ER. IV fluids given.
Nerve pain mouth,  right lower gum tooth area.  Saw dentist and no issue with teeth. Xray done.
I got Covid 9/9/21; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I got Covid 9/9/21) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced COVID-19 (I got Covid 9/9/21). At the time of the report, COVID-19 (I got Covid 9/9/21) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medication information were provided. No treatment information were provided.
NAUSEA; HEADACHE; INTENSE DIZZINESS WHICH FEELS LESS DIZZY WHEN STANDING ON SOLID FLOOR OR NOT MOVING; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-MAR-2021 to left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 12-MAR-2021, the subject experienced intense dizziness which feels less dizzy when standing on solid floor or not moving. On 13-MAR-2021, the subject experienced nausea. On 13-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from intense dizziness which feels less dizzy when standing on solid floor or not moving, nausea, and headache. This report was non-serious.
aches; chills; This is a spontaneous report from contactable nurse (patient) via a sales representative. A patient of unspecified age and gender started to receive BNT162B2 (also reported as "Pfizer COVID Vaccine"), via an unspecified route of administration from an unspecified date to an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient was given 2nd dose of the COVID vaccine and 24 hours later, the patient had aches and chills. The outcome of the events was unknown.    No follow-up attempts are possible. Information on the lot/batch number has been requested.
After first dose of Moderna on 12/31, went to the ER for chest pain and L arm numbness on 1/7/21. She was told it was a migraine equivalent. She already submitted a VAERS form but she did not inform office about the event.
I am still having a pain.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 29Sep2021 (Lot number: FF2587) at the age of 50 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Diabetes mellitus" (unspecified if ongoing), notes: Verbatim: Diabetic. The patient's concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "I am still having a pain.". Therapeutic measures were taken as a result of pain.  Additional Information: Treatment: Consumer stated, "For the Vaccine, I mean the diabetic or the Vaccine problem? Just Tylenol."  No follow-up attempts are possible. No further information is expected.
Contracted the COVID virus after all three doses of the vaccine. Received the antibody infusion. Still sick going on four weeks now.
Covid19 breakthrough.  1st vaccine received on 05/01/2021 and 2nd vaccine on 05/22/2021.  70 y/o male with PMHx of HTN, HLD, COPD, OSA with CPAP presents to ED with c/o SOB and cough x3 days.  Pt O2sat on room air 97%, Afebrile and CXR with no acute findings.  CTA Chest with scattered pulmonary nodules.  Pt admitted and started on IV Steroids and ABX.
Pt recvd 3 doses of Engerix-B 5NOV90, 4DEC90, & 9MAY91 & 9SEP91 it was determined that pts titer was neg p/3 doses of Engerix-B;
A relative got vaccine, shingles, keeps reaccuring/suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: A relative got vaccine, shingles, keeps reaccuring/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 25-MAR-2023 This case was reported by a patient's relative via interactive digital media. The patient got shingles vaccine and shingles was keep reoccurring. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Around the time of the 1st dose of Pfizer Covid-19 vaccine, noticeable deteriorating hearing loss, more rapidly in right ear. Then 2 weeks after 2nd dose, sudden profound hearing loss in left ear occurred.
Around 1/10/21, site of injection started inching and was red. On 1/11/21, about a 2 inch redness around injection site, no itch. On 1/12/21, 2 inch redness remains, but the inside of the red area is my skin color, no itch.
Swollen lymph node in the armpit of the left arm where the vaccine was given. Arm with pain, arm cramp and hand cramp. Pain in the back and chest.
No Adverse event; 9 individuals that received Moderna Bivalent Booster 0.25mL dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (9 individuals that received Moderna Bivalent Booster 0.25mL dose) and NO ADVERSE EVENT (No Adverse event) in a 55-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030G22B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 13-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (9 individuals that received Moderna Bivalent Booster 0.25mL dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (9 individuals that received Moderna Bivalent Booster 0.25mL dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (9 individuals that received Moderna Bivalent Booster 0.25mL dose).    No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Oct-2022: Follow up received contains lot number had been added.
Swelling and hardness at site of injection (swollen area about 3 and 1/2 inches in diameter.  I referred her to call her dr to discuss it.
Fever to 102.3, Chills, Headache, Body aches, Neck pain, Warm erythema at injection site, Sore throat
Patechia in finger tips and then blood work was done Elevated liver enzymes. Two weeks after second dose. Prior to the vaccine blood test were all normal. 2 months have passed and enzymes are still elevated. Going for a liver biopsy
no adverse reaction reported by patient. On September 26th, 2022 we were notified by the pharmacy on September 26th, 2022 that the vaccine was unfrozen on August 16th, 2022.  The expiration date on the vial is September 11, 2022.
Initially, experienced swelling in left  foot, leg, progressive pain, difficulty walking.  Referred for test, after seeing doctor on  4/21/21, progressive pain, gradual  and increasing shortness of breath. Went to Urgent care on  4/26/21. Recommended Emergency care. Hospitalized 4/26/21 to 4/30/21. Diagnosed DVT, Pulmonary Embolism, Afib.
Information has been received from a lawyer regarding a case in litigation concerning an approximately 78 year old male patient. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On an unknown date in 2014, the patient was administered the ZOSTAVAX by a physician (lot number, dosage and route of administration not provided). On an unknown date in 2014, the patient was treated by the physician for the following injury resulting from his ZOSTAVAX use: Shingles. The patient claims damages including: injury to himself and economic losses. The outcome of the shingles is unknown. Additional information has been requested.
Nurse on duty at our clinic was discovered to have given a dose of Pfizer to this patient when vial was punctured and reconstituted 3 days prior.  Nurse states she first punctured vial on 10/26/2021 and reconstituted to administer a few doses on that day.  She then proceeded to return the Pfizer vaccine vial to the fridge at 2-8 degrees C and re-punctured vial on 10/29/2021 to administer to this patient. Patient remained in clinic x 20 minutes and no s/s reaction reported up to this date.
After I received my second dose of the COVID-19 vaccine, menstrual cycle became out of sync and my period was 10 days late. This has continued since I have received my vaccine and now my menstrual cycle is 38 days as opposed to 28 days. I would like to note that I have had regular periods for over 10 years, therefore, I know that the vaccine has caused this. Additionally, I have never been pregnant. I am also experiencing difficulty achieving orgasm with a partner and alone which has also never occurred before.
A dose of Moderna 0.5ml was given IM vs Moderna 0.25 ml for booster.
Information has been received from a pharmacist concerning a male physician who was vaccinated with a dose of PNEUMOVAX (662663/0980X). It was not known if this was the first dose or not. Subsequently the patient experienced soreness at the injection site. At the time of reporting, the patient recovered. The patient sought medical attention via contacting the pharmacist. This is one of several reports from the same source. Additional information has been requested.
Received DTA, MMR, IPV and PCV on 8/12/03. MMR-IPV given in L arm on Thus 8/14/03 L arm swollen from shoulder to elbow with redness and itching-was treated at the med center with Prednisone and given Epipen.
Devel swelling @ site w/in 24 hrs @ time of exam on 5DEC91 3 cm area on rt thigh of redness, induration & pinpoint of purulence;
Information has been received from a certified medical assistant concerning a 16 year old female with morphine allergy and no relevant medical history who was vaccinated with GARDASIL during the first trimester of her pregnancy.  The vaccine was provided at another location.  Dose, route of administration and lot number were not provided.  There was no concomitant medication.  Ultrasounds, fetal echo, pulmonary function tests were performed and no results were provided.  Prenatal testing revealed that the fetus had multiple skeletal abnormalities (dysplasias) and was not expected to survive after delivery.  The patient contacted the physician to seek unspecified medical attention.  Additional information has been requested.
massive migraine headache; Couldn't lift her arms.; Arms started to hurts; Veins in the arms popped out as bluish purplish color; Stomach pain as if punched by someone; Feels so sick; Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (massive migraine headache), LIMB DISCOMFORT (Couldn't lift her arms.), PAIN IN EXTREMITY (Arms started to hurts), VEIN DISCOLOURATION (Veins in the arms popped out as bluish purplish color) and ABDOMINAL PAIN UPPER (Stomach pain as if punched by someone) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Vertigo.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced MIGRAINE (massive migraine headache), LIMB DISCOMFORT (Couldn't lift her arms.), PAIN IN EXTREMITY (Arms started to hurts), VEIN DISCOLOURATION (Veins in the arms popped out as bluish purplish color), ABDOMINAL PAIN UPPER (Stomach pain as if punched by someone), MALAISE (Feels so sick) and NAUSEA (Nauseated). On 20-Mar-2021, PAIN IN EXTREMITY (Arms started to hurts) had resolved. At the time of the report, MIGRAINE (massive migraine headache), LIMB DISCOMFORT (Couldn't lift her arms.), VEIN DISCOLOURATION (Veins in the arms popped out as bluish purplish color), ABDOMINAL PAIN UPPER (Stomach pain as if punched by someone), MALAISE (Feels so sick) and NAUSEA (Nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Products known to had been used by the patient, within two weeks prior to the event, included medications for Vertigo.  Treatment for events included tylenol and other non specified prescribed medicines.
This spontaneous report as received from a consumer refers to a 37 year old female patient. On an unknown date the patient was vaccinated with, 1 DF ZOSTAVAX. No other co-suspects were reported. No concomitant medications were reported. She was administered ZOSTAVAX at the age of 37 years old. No treatment information was reported. No adverse event was reported. Additional information has been requested.
Slight swelling (Nickel size) around injection site noted after injection. No other symptom noted or reported by pt.  Patient was assessed by provider on site. Ice pack offered, pt. applied for 5-10 minutes in intervals. Pt. observed for total of 30 minutes. Swelling subsided, no redness, or indwelling noted. Provider aware, pt. left without verbalizing any other symptoms. VIS and CDC information provided to pt.
Inconsolable crying 2 days after having received vaccines. some crying on day after vaccines erythema exema on inj site L leg
Information has been received from a vaccine coordinator referring to unspecified patients. The patients' concurrent condition and medical history were not reported. Concomitant medication was not provided. On an unknown date, the patients were vaccinated with ROTATEQ (dose, unit, route unknown, lot # L033694, expiration date 16-JUN-2017). No adverse event was reported. No product quality issue involved. Additional information has been requested.
Immediate pain in arms and dizziness. Chronic stomach pain, chronic fatigue, roaming muscle pain and atrophy to muscle sites (upper extremity, lower extremities, headaches.  6/13/2008 MR received for OVs and consultations beginning 1/22/2008 with a healthy WCC.  Vax given, TDaP, Varicella, Gardasil and Menactra. Seen again 2/13 and 2/28/08 with c/o Flu-like sx, stomach aches, feeling weak and tired, and abdominal pain. DX: URI.  Periumbilical Pain. Fatigue and Malaise. Consult 3/11/08 for above c/o as well as SOB with Impression: Adverse reaction to vaccination-Gardasil. Drug Allergy. Fatigue and Malaise. Seen by PCP again with new c/o pain in the back and calf muscles. Continues to have abdominal pain. Added DX:  Unspecified Myalgia and Myositis. W/U (-) thus far.
he got both doses then a few days later he died; This is a spontaneous report from a contactable consumer reporting for a friend's father.  A male patient of an unspecified age received the second dose of bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration on an unspecified date at single dose  for Covid-19 immunisation .  The patient medical history and  concomitant medications were not reported.  The patient received the first dose on an unknown date. The patient  died few days after receiving the second dose of the vaccine  on an unspecified date.   It was not reported if an autopsy was performed.  Information about lot/batch number has been requested.; Reported Cause(s) of Death: he got both doses then a few days later he died
Pt complained of dizziness, pt's skin color was pale after Immunization administration and fainted, eyes rolled back. Med. assistance was requested thru 911. Pt admitted to hospital.
pt recv vax & was found to be a nonresponder p/3rd & 4th doses of vax;pt also exp numbness & tingling in lt wrist;
Woke up the neck day with a headache, chills, body ache, back pain, and sensitive skin. Got worse throughout the day. Temperature at 10:00 pm (14 hrs after injection) was 99.1 degrees Fahrenheit. Went to bed and woke up the next day feeling better. Slight sensitive skin, sore neck, and headache. Did not urinate for 9 hours.
potential Adverse event; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (potential Adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (potential Adverse event). At the time of the report, VACCINATION COMPLICATION (potential Adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   No information on treatment is provided by the reporter.
10/28/20 Patient called clinic & said 3 - 4 HRS after injections he developed decreased back pain, shortness of breath (increased) fever, loss of appetite, nausea, eyes swelled a little, headache. Took double dose of nebulizer treatment. 10/24 - 0300 pt said felt better.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Aug2021 as dose 3 (booster), single (Lot number: fc3182) and on 01Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 75 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: BYSTOLIC, start date: Jan2010; LOSARTIN, start date: Jan2010; SPIRONOLACTON, start date: Jan2017; AMLODIPINE, start date: Aug2021; SIMVASTATIN, start date: Jan2007, stop date: 22Aug2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received antiviral treatment of Paxlovid. Treatment start date: 22Aug2022, Treatment stop date: 26Aug2022, Lot number: ge1577,Indication: Treatment of COVID-19. Adverse event Severe stomach discomfort. Inability to eat or drink for 36 hours. Adverse event start date 25Aug2022. If patient recovered Recovering. Known allergies no.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
-Mild fever -Decreased appetite -Runny nose -Rash on torso and face Onset Friday, May 10, stabilized Sunday, May 12.
A 14 year old received the 1st dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 14 year old received the 1st dose of the Moderna COVID-19 vaccine) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 14 year old received the 1st dose of the Moderna COVID-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 14 year old received the 1st dose of the Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Height of patient was  5 Ft 10 No concomitant medication were provided. No treatment information were given.
Patient came in for for an appointment with the provider and for 3rd dose of covid vaccine today. Patient was given a 12+ pfizer vaccine at 3:00pm by MA that was expired due to it being drawn up on 5/3 at 0750.  This was dose #3 for patient. Patient was observed for 20 minutes by RN for any side effects. Mom informed by RN of any possible reactions and of vaccine given. No distress/side effects noted in patient when discharged. RN and Dr. notified.